Stockreport

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know [Yahoo! Finance]

CG Oncology, Inc.  (CGON) 
PDF 1,059,375 shares in the fourth quarter for an estimated $43.84 million based on quarterly average pricing, according to a February 17, 2026, SEC filing. What happened [Read more]